A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by the FDA, and the partners have now withdrawn a filing intended to get the ...

Every month, The FADER's Vivian Medithi showcases all the standout rap songs from the past 30-ish days in one unranked list. Over the sort of subtle ShunGu beat that makes you sit up and listen a ...

If you’re within a certain age bracket, you’ll remember the news being delivered with grave certainty: The iPod is going to end the album as we know it. Yet for as many 99-cent songs as were purchased ...

For those unaware, the new Superman Mythic drops when a giant ice block crashes into the map shortly after the first Storm circle begins to close. Once it lands, the first player to interact with the ...

When Merck & Co. and Daiichi Sankyo last year received an FDA complete response letter for their HER3-directed antibody-drug conjugate (ADC) patritumab deruxtecan, the companies hoped to address ...

As the year comes to an end, we’re paying tribute to our favorite albums and songs released across our favorite genres. This week, we tackled the very best K-pop songs of 2024, and today we’ve ...

Ali is blessed with the opportunity to use his love of gaming and anime, along with his writing skills, to create intriguing and educational content for a wide range of topics as a passionate and ...

AstraZeneca and Daiichi Sankyo confirmed today that they have decided to voluntarily withdraw their EU marketing application for datopotamab deruxtecan (Dato-DXd) in lung cancer, based on regulator ...